Effector responses in RA patients were more impaired in senescent CD4+ T cells compared with CD27−CD28− CD8+ T cells and central memory CD4+ T cells, suggesting a selective functional vulnerability in this highly differentiated CD4+ subset. This evidence concerns the gene CD8A and rheumatoid arthritis.